LEVETIRACETAM DEXCEL 1000

Land: Israel

Språk: engelska

Källa: Ministry of Health

Aktiva substanser:

LEVETIRACETAM

Tillgänglig från:

DEXCEL PHARMA TECHNOLOGIES LTD

ATC-kod:

N03AX14

Läkemedelsform:

TABLETS

Sammansättning:

LEVETIRACETAM 1000 MG

Administreringssätt:

PER OS

Receptbelagda typ:

Required

Tillverkad av:

DEXCEL LTD, ISRAEL

Terapeutisk grupp:

LEVETIRACETAM

Terapiområde:

LEVETIRACETAM

Terapeutiska indikationer:

Levetiracetam Dexcel is indicated as monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy.Levetiracetam Dexcel is indicated as adjunctive therapy:• In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.• In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy.• In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy.

Tillstånd datum:

2018-03-31